Altre lingue Talphera, Inc.

Azioni

TLPH

US00444T2096

Mercato chiuso - Nasdaq Altri mercati azionari 19:00:00 03/07/2024			Variaz. 5gg	Var. 1 gen.
0,92 ^USD	0,00%		+4,55%	+25,17%

14/05	Talphera, Inc. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
14/05	Transcript : Talphera, Inc., Q1 2024 Earnings Call, May 14, 2024

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Talphera Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)	20/05
Talphera to Participate at A.G.P. Virtual Healthcare Conference	16/05
Talphera, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
Talphera: Q1 Earnings Snapshot	14/05
Talphera, Inc. Appoints Dr. Shakil Aslam as Chief Development Officer, Effective May 20, 2024	14/05
Talphera: Q4 Earnings Snapshot	06/03
Talphera, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	06/03
Talphera, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	06/03
Talphera Announces Reduction in Size of its Board of Directors from Ten to Seven Members	04/03
Talphera, Inc. Announces Management Changes	01/03
Talphera Announces Reduction in Size of its Board of Directors from Ten to Seven Members	01/03
Talphera, Inc. Appoints Abhinav Jain to Serve as a Class II Director	22/01
XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA Acquisition	19/01
XOMA Acquires Interest in Pain Management Medication Dsuvia for $8 Million	18/01
Talphera Announces $26 Million Capital Commitment Through a Combination of a Non-Dilutive Royalty Monetization and Equity Offering	18/01
XOMA Corporation acquired DSUVIA® of Talphera, Inc. for $8 million.	18/01
Talphera, Inc. announced that it expects to receive $16 million in funding from Nantahala Capital Management, LLC, Rosalind Advisors, Inc.	17/01
AcelRx Pharmaceuticals, Inc. will Change its Ticker to TLPH from ACRX	10/01
AcelRx Announces Rebranding With Name Change to Talphera, Inc.	09/01
Talphera Expects to Initiate the Registrational Study of Niyad	09/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Talphera, Inc.

Azioni

TLPH

US00444T2096

Altre lingue

Filtri